Abstract:Purpose: Immunotherapy (IT) and radiotherapy (RT) can act synergistically, enhancing antitumor response beyond what either treatment can achieve separately. Anecdotal reports suggest that these results are in part due to the induction of an abscopal effect on non-irradiated lesions. Systematic data on incidence of the abscopal effect are scarce, while the existence and the identification of predictive signatures or this phenomenon are lacking. The purpose of this pre-clinical investigational work is to shed more light on the subject by identifying several imaging features and blood counts, which can be utilized to build a predictive binary logistic model. Materials and methods: This proof-of-principle study was performed on Lewis Lung Carcinoma in a syngeneic, subcutaneous murine model. Nineteen mice were used: four as control and the rest were subjected to combined RT plus IT regimen. Tumors were implanted on both flanks and after reaching volume of ~200 mm3 the animals were CT and MRI imaged and blood was collected. Quantitative imaging features (radiomics) were extracted for both flanks. Subsequently, the treated animals received radiation (only to the right flank) in three 8 Gy fractions followed by PD-1 inhibitor administrations. Tumor volumes were followed and animals exhibiting identical of better tumor growth delay on the non-irradiated (left) flank as compared to the irradiated flank were identified as experiencing an abscopal effect. Binary logistic regression analysis was performed to create models for CT and MRI radiomics and blood counts, which are predictive of the abscopal effect. Results: Four of the treated animals experienced an abscopal effect. Three CT and two MRI radiomics features together with the pre-treatment neutrophil-to-lymphocyte (NLR) ratio correlated with the abscopal effect. Predictive models were created by combining the radiomics with NLR. ROC analyses indicated that the CT model had AUC of 0.846, while the MRI model had AUC of 0.946. Conclusions: The combination of CT and MRI radiomics with blood counts resulted in models with AUCs of 1 on the modeling dataset. Application of the models to the validation dataset exhibited AUCs above 0.84, indicating very good predictive power of the combination between quantitative imaging and blood counts.

A unique apudoma producing the glucagonoma and gastrinoma syndromes.

Neuroblastoma, retinoblastoma, and brain tumors in children.

Using immunotherapy to boost the abscopal effect

Immune mechanisms mediating abscopal effects in radioimmunotherapy

Abscopal Effects of Local Radiotherapy Are Dependent on Tumor Immunogenicity

Killing two birds with one stone: Abscopal Effect Mechanism and its application prospect in radiotherapy

Recent Research Progress of Abscopal Effect in Tumor Radiotherapy

Abscopal effect of radiotherapy combined with immune checkpoint inhibitors

Combined Radiotherapy and Hyperthermia: A Systematic Review of Immunological Synergies for Amplifying Radiation-Induced Abscopal Effects

Systemic Effects of Radiation Therapy-Induced Abscopal Responses in Patients with Advanced Lung Cancer

Abscopal Effect of Stereotactic Radiotherapy Combined with Anti‐pd‐1/pd‐l1 Immunotherapy: Mechanisms, Clinical Efficacy, and Issues

Radiotherapy-Mediated Immunomodulation and Anti-Tumor Abscopal Effect Combining Immune Checkpoint Blockade

Toward prediction of abscopal effect in radioimmunotherapy: Pre-clinical investigation

Psychologic characteristics of patients with female urethral syndrome.

Brachytherapy attains abscopal effects when combined with immunostimulatory monoclonal antibodies

The abscopal effect of immune-radiation therapy in recurrent and metastatic cervical cancer: a narrative review

Nanotechnology-enhanced radiotherapy and the abscopal effect: Current status and challenges of nanomaterial-based radio-immunotherapy

ATP-dependent proteases in prokaryotic and eukaryotic cells.

Effect of hypofractionated radiotherapy, PD-1 immunotherapy, and anti-angiogenic therapy on abscopal responses and the tumor microenvironment.

Radiotherapy and Immunotherapy: a Beneficial Liaison?

Radiotherapy combined with immunotherapy: the dawn of cancer treatment